Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Simani, Leila, Ramezani, Mahtab, Darazam, Ilad Alavi et al. · Journal of neurovirology · 2021 · DOI
Quick Summary
This study looked at whether people who survived COVID-19 developed chronic fatigue syndrome (ME/CFS) or PTSD within 6 months of infection. Among 120 COVID-19 survivors in Iran, about 2.5% met the criteria for ME/CFS and 5.8% showed signs of PTSD. Interestingly, the researchers found that having PTSD was not linked to developing ME/CFS in these patients.
Why It Matters
This study provides early evidence about ME/CFS prevalence in COVID-19 survivors and challenges assumptions that psychological stress from severe infection necessarily drives post-viral fatigue. Understanding whether post-COVID ME/CFS shares mechanisms with PTSD has implications for both diagnosis and treatment approaches.
Observed Findings
17.5% of COVID-19 survivors reported fatigue symptoms at 6 months
2.5% (n=3) met full CFS diagnostic criteria
5% (n=6) met criteria for CFS-like with insufficient fatigue syndrome
5.8% screened positive for PTSD
No significant association found between CFS and PTSD after adjusting for covariates
Inferred Conclusions
Post-COVID ME/CFS prevalence (2.5%) is similar to rates in the general population, suggesting COVID-19 may not substantially increase ME/CFS risk
PTSD development in COVID-19 survivors is not associated with increased ME/CFS risk, suggesting distinct pathophysiologic mechanisms
Medical systems should monitor psychological morbidities in COVID-19 survivors despite modest PTSD/CFS rates
Remaining Questions
What are the long-term trajectories of these conditions beyond 6 months?
Why does this study's CFS prevalence differ from other long-COVID cohorts, and what methodological factors explain this?
What underlying mechanisms cause ME/CFS in some COVID-19 survivors if not trauma-related psychological stress?
What This Study Does Not Prove
This study does not establish that PTSD cannot occur alongside ME/CFS; it only found no statistical association in this specific population. The reliance on screening questionnaires rather than definitive clinical diagnoses means true prevalence may differ. Cross-sectional design cannot determine causation or temporal relationships—it cannot confirm whether COVID-19 actually caused the ME/CFS cases observed.